SERES THERAPEUTICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
Item 7.01. Regulation FD Disclosure. On June 7, 2022, Seres Therapeutics, Inc. posted a slide presentation on the topline data from the ECOSPOR IV open-label study of SER-109 in... | June 7, 2022
Source: marketscreener.com